Pricing Log in Create free account

Charles River Laboratories International, Inc. (CRL) vs ICON PLC (ICLR)

Charles River Laboratories International, Inc. and ICON PLC are both Diagnostics & Research companies. Charles River Laboratories International, Inc. and ICON PLC are of similar size ($14.6B and $13.5B). Charles River Laboratories International, Inc. has negative trailing earnings, so its P/E is not meaningful; ICON PLC trades at 254×. ICON PLC grew revenue faster over the last twelve months: 3.26% against −0.74%. ICON PLC has the higher net margin (0.51% vs −5.96%) and the higher return on invested capital (1.57% vs 1.07%). Across the 21 metrics below, ICON PLC leads on 17 and Charles River Laboratories International, Inc. on 4.

Valuation

Metric CRL ICLR Diagnostics & Research median
P/E n/m 254.23 35.56
P/S 3.60 1.58 4.37
P/B 5.06 1.39 3.06
Price to free cash flow 38.84 14.80 35.76
EV/EBITDA 30.42 23.30 24.35
EV/Sales 4.21 1.87 5.51
Earnings yield (1.61%) 0.39% (1.89%)
Free cash flow yield 2.57% 6.76% (0.15%)

Profitability

Metric CRL ICLR Diagnostics & Research median
Gross margin 32.67% 23.91% 50.89%
Operating margin 2.25% 3.57% (8.57%)
Net margin (5.96%) 0.51% (6.37%)
Free cash flow margin 9.27% 10.66% 0.00%
Return on equity (7.69%) 0.45% (2.92%)
Return on assets (3.16%) 0.26% (6.71%)
Return on invested capital 1.07% 1.57% 0.00%

Growth

Metric CRL ICLR Diagnostics & Research median
Revenue growth (TTM) (0.74%) 3.26% 7.69%
EPS growth (last fiscal year) (1,555.00%) (69.57%) 25.92%
Revenue growth, 5-year CAGR 6.55% 24.15% 7.40%
Net income growth, 5-year CAGR 0.00% (7.15%) 0.00%

Health

Metric CRL ICLR Diagnostics & Research median
Debt to equity 0.92 0.36 0.11
Current ratio 1.35 0.95 2.02
Net debt to EBITDA 3.24 3.34 0.70

Dividend

Metric CRL ICLR Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric CRL ICLR Diagnostics & Research median
Market cap 14.62b 13.51b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack